Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. provides services to government and commercial customers, aiming to make biology easier to engineer. The company operates through two business segments: cell engineering and biosecurity. In the cell engineering segment, Ginkgo offers tools and biological research and development (R&D) services across various industries. These services support customers in medicine for developing new therapeutics and vaccines, in agriculture for advancing food system sustainability and security, in industrial biotechnology for manufacturing products with improved performance and lower environmental impact, and in government for advancing new R&D priorities of strategic importance to the United States and its allies. Traditionally, biotech R&D involves in-house labs with scientists conducting manual experiments over several years to develop products. The biosecurity segment provides services to customers focused on identifying, monitoring, preventing, mitigating, and protecting against biological threats.